CHEMED CORP (CHE) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CHE - US16359R1032 - Common Stock
451.9 USD
-7.03 (-1.53%)
451.9 USD
0 (0%)
CHE gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making CHE a very profitable company, without any liquidiy or solvency issues. CHE is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year CHE was profitable.
- In the past year CHE had a positive cash flow from operations.
- CHE had positive earnings in each of the past 5 years.
- In the past 5 years CHE always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 17.17%, CHE belongs to the top of the industry, outperforming 99.02% of the companies in the same industry.
- The Return On Equity of CHE (25.89%) is better than 92.16% of its industry peers.
- CHE has a Return On Invested Capital of 21.27%. This is amongst the best in the industry. CHE outperforms 95.10% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for CHE is significantly above the industry average of 9.21%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.17% | ||
| ROE | 25.89% | ||
| ROIC | 21.27% |
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
1.3 Margins
- CHE has a better Profit Margin (11.02%) than 95.10% of its industry peers.
- In the last couple of years the Profit Margin of CHE has grown nicely.
- CHE has a better Operating Margin (14.60%) than 88.24% of its industry peers.
- CHE's Operating Margin has improved in the last couple of years.
- CHE has a Gross Margin of 32.88%. This is in the better half of the industry: CHE outperforms 63.73% of its industry peers.
- In the last couple of years the Gross Margin of CHE has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.6% | ||
| PM (TTM) | 11.02% | ||
| GM | 32.88% |
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CHE is creating value.
- Compared to 1 year ago, CHE has less shares outstanding
- Compared to 5 years ago, CHE has less shares outstanding
- CHE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- CHE has an Altman-Z score of 11.90. This indicates that CHE is financially healthy and has little risk of bankruptcy at the moment.
- CHE has a better Altman-Z score (11.90) than 96.08% of its industry peers.
- CHE has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
- CHE's Debt to FCF ratio of 0.00 is amongst the best of the industry. CHE outperforms 94.12% of its industry peers.
- A Debt/Equity ratio of 0.00 indicates that CHE is not too dependend on debt financing.
- CHE has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. CHE outperforms 86.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 11.9 |
ROIC/WACC2.38
WACC8.93%
2.3 Liquidity
- CHE has a Current Ratio of 1.35. This is a normal value and indicates that CHE is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.35, CHE perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
- A Quick Ratio of 1.33 indicates that CHE should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.33, CHE is in line with its industry, outperforming 54.90% of the companies in the same industry.
- The current and quick ratio evaluation for CHE is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.33 |
3. Growth
3.1 Past
- The earnings per share for CHE have decreased by -3.97% in the last year.
- The Earnings Per Share has been growing by 10.64% on average over the past years. This is quite good.
- Looking at the last year, CHE shows a small growth in Revenue. The Revenue has grown by 6.45% in the last year.
- CHE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.63% yearly.
EPS 1Y (TTM)-3.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-6.56%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.09%
3.2 Future
- Based on estimates for the next years, CHE will show a small growth in Earnings Per Share. The EPS will grow by 6.13% on average per year.
- The Revenue is expected to grow by 5.17% on average over the next years.
EPS Next Y-3.15%
EPS Next 2Y5.45%
EPS Next 3Y6.13%
EPS Next 5YN/A
Revenue Next Year5.02%
Revenue Next 2Y5.61%
Revenue Next 3Y5.17%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- CHE is valuated rather expensively with a Price/Earnings ratio of 20.54.
- Compared to the rest of the industry, the Price/Earnings ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 69.61% of the companies listed in the same industry.
- CHE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.38.
- The Price/Forward Earnings ratio is 17.56, which indicates a rather expensive current valuation of CHE.
- CHE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CHE is cheaper than 73.53% of the companies in the same industry.
- CHE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.29, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.54 | ||
| Fwd PE | 17.56 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CHE is valued a bit cheaper than 61.76% of the companies in the same industry.
- 70.59% of the companies in the same industry are more expensive than CHE, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.75 | ||
| EV/EBITDA | 14.45 |
4.3 Compensation for Growth
- CHE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.93
EPS Next 2Y5.45%
EPS Next 3Y6.13%
5. Dividend
5.1 Amount
- CHE has a yearly dividend return of 0.52%, which is pretty low.
- CHE's Dividend Yield is rather good when compared to the industry average which is at 0.59. CHE pays more dividend than 81.37% of the companies in the same industry.
- With a Dividend Yield of 0.52, CHE pays less dividend than the S&P500 average, which is at 1.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
5.2 History
- The dividend of CHE is nicely growing with an annual growth rate of 8.02%!
- CHE has been paying a dividend for at least 10 years, so it has a reliable track record.
- CHE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)8.02%
Div Incr Years16
Div Non Decr Years21
5.3 Sustainability
- CHE pays out 11.01% of its income as dividend. This is a sustainable payout ratio.
- CHE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP11.01%
EPS Next 2Y5.45%
EPS Next 3Y6.13%
451.9
-7.03 (-1.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-28 2025-10-28/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners101.64%
Inst Owner Change0.17%
Ins Owners1.52%
Ins Owner Change-7.07%
Market Cap6.40B
Revenue(TTM)2.53B
Net Income(TTM)278.81M
Analysts87.5
Price Target585.74 (29.62%)
Short Float %4.72%
Short Ratio4.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
Yearly Dividend1.83
Dividend Growth(5Y)8.02%
DP11.01%
Div Incr Years16
Div Non Decr Years21
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.99%
Min EPS beat(2)-15.11%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-4.45%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)2
Avg EPS beat(8)-3.19%
EPS beat(12)4
Avg EPS beat(12)-2.23%
EPS beat(16)8
Avg EPS beat(16)-1.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-2.53%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.53%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.28%
Revenue beat(12)2
Avg Revenue beat(12)-1.05%
Revenue beat(16)2
Avg Revenue beat(16)-1.24%
PT rev (1m)0%
PT rev (3m)-0.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.58%
EPS NY rev (1m)0%
EPS NY rev (3m)0.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.54 | ||
| Fwd PE | 17.56 | ||
| P/S | 2.53 | ||
| P/FCF | 17.75 | ||
| P/OCF | 15.25 | ||
| P/B | 5.94 | ||
| P/tB | 19.7 | ||
| EV/EBITDA | 14.45 |
EPS(TTM)22
EY4.87%
EPS(NY)25.73
Fwd EY5.69%
FCF(TTM)25.46
FCFY5.63%
OCF(TTM)29.64
OCFY6.56%
SpS178.72
BVpS76.04
TBVpS22.94
PEG (NY)N/A
PEG (5Y)1.93
Graham Number194.01
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.17% | ||
| ROE | 25.89% | ||
| ROCE | 27.75% | ||
| ROIC | 21.27% | ||
| ROICexc | 23.56% | ||
| ROICexgc | 62.89% | ||
| OM | 14.6% | ||
| PM (TTM) | 11.02% | ||
| GM | 32.88% | ||
| FCFM | 14.24% |
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
ROICexc(3y)25.21%
ROICexc(5y)25.79%
ROICexgc(3y)67.33%
ROICexgc(5y)75.46%
ROCE(3y)28.73%
ROCE(5y)30.03%
ROICexgc growth 3Y-5.61%
ROICexgc growth 5Y0.34%
ROICexc growth 3Y-1.58%
ROICexc growth 5Y4.43%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
F-Score7
Asset Turnover1.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 92.02% | ||
| Cap/Sales | 2.34% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 96.74% | ||
| Profit Quality | 129.28% | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.33 | ||
| Altman-Z | 11.9 |
F-Score7
WACC8.93%
ROIC/WACC2.38
Cap/Depr(3y)89.59%
Cap/Depr(5y)94.39%
Cap/Sales(3y)2.41%
Cap/Sales(5y)2.56%
Profit Quality(3y)107.8%
Profit Quality(5y)110.23%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-6.56%
EPS Next Y-3.15%
EPS Next 2Y5.45%
EPS Next 3Y6.13%
EPS Next 5YN/A
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.09%
Revenue Next Year5.02%
Revenue Next 2Y5.61%
Revenue Next 3Y5.17%
Revenue Next 5YN/A
EBIT growth 1Y-7.92%
EBIT growth 3Y4.05%
EBIT growth 5Y8.18%
EBIT Next Year14.85%
EBIT Next 3Y10.29%
EBIT Next 5YN/A
FCF growth 1Y39.38%
FCF growth 3Y13.77%
FCF growth 5Y8.19%
OCF growth 1Y30.35%
OCF growth 3Y10.6%
OCF growth 5Y6.75%
CHEMED CORP / CHE FAQ
What is the fundamental rating for CHE stock?
ChartMill assigns a fundamental rating of 7 / 10 to CHE.
What is the valuation status of CHEMED CORP (CHE) stock?
ChartMill assigns a valuation rating of 5 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.
Can you provide the profitability details for CHEMED CORP?
CHEMED CORP (CHE) has a profitability rating of 9 / 10.
Can you provide the financial health for CHE stock?
The financial health rating of CHEMED CORP (CHE) is 9 / 10.
What is the earnings growth outlook for CHEMED CORP?
The Earnings per Share (EPS) of CHEMED CORP (CHE) is expected to decline by -3.15% in the next year.